Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-glutamine for Pulmonary Hypertension in Non-transfusion-dependent Thalassemia
NCT07210450Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2023
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glutamine in pulmonary hypertension (PH), sponsored by Mazandaran University of Medical Sciences. Started Aug 2023; status: completed.
02
Drugs
glutamine
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07210450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07210450.